|
US4166452A
(en)
|
1976-05-03 |
1979-09-04 |
Generales Constantine D J Jr |
Apparatus for testing human responses to stimuli
|
|
US4256108A
(en)
|
1977-04-07 |
1981-03-17 |
Alza Corporation |
Microporous-semipermeable laminated osmotic system
|
|
US4265874A
(en)
|
1980-04-25 |
1981-05-05 |
Alza Corporation |
Method of delivering drug with aid of effervescent activity generated in environment of use
|
|
LU86084A1
(fr)
|
1985-09-20 |
1987-04-02 |
Faco Sa |
Apparei de massage electrique
|
|
US5102417A
(en)
|
1985-11-07 |
1992-04-07 |
Expandable Grafts Partnership |
Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
|
|
US4800882A
(en)
|
1987-03-13 |
1989-01-31 |
Cook Incorporated |
Endovascular stent and delivery system
|
|
US4886062A
(en)
|
1987-10-19 |
1989-12-12 |
Medtronic, Inc. |
Intravascular radially expandable stent and method of implant
|
|
WO1990013332A1
(en)
|
1989-05-11 |
1990-11-15 |
Cedars-Sinai Medical Center |
Stent with sustained drug delivery
|
|
EP0470246B1
(en)
|
1990-02-28 |
1995-06-28 |
Medtronic, Inc. |
Intralumenal drug eluting prosthesis
|
|
US5419760A
(en)
|
1993-01-08 |
1995-05-30 |
Pdt Systems, Inc. |
Medicament dispensing stent for prevention of restenosis of a blood vessel
|
|
US5429634A
(en)
|
1993-09-09 |
1995-07-04 |
Pdt Systems |
Biogenic implant for drug delivery and method
|
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
|
US5833651A
(en)
|
1996-11-08 |
1998-11-10 |
Medtronic, Inc. |
Therapeutic intraluminal stents
|
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
EP1193256A1
(en)
*
|
2000-09-27 |
2002-04-03 |
Applied Research Systems ARS Holding N.V. |
Pharmaceutically active benzsulfonamide derivatives as inhibitors of JNK proteins
|
|
JP2004526733A
(ja)
|
2001-03-20 |
2004-09-02 |
メルク エンド カムパニー インコーポレーテッド |
強力な細胞接着阻害剤としての置換ｎ−アリールスルホニル−プロリン誘導体
|
|
AR036366A1
(es)
|
2001-08-29 |
2004-09-01 |
Schering Corp |
Derivados de piperidina utiles como antagonistas de ccr5, composiciones farmaceuticas, el uso de dichos derivados para la fabricación de un medicamento y un kit
|
|
AR037352A1
(es)
|
2001-11-14 |
2004-11-03 |
Schering Corp |
Compuestos ligandos de los receptores de los cannabinoides, una composicion farmaceutica , y el uso de dichos compuestos para la manufactura de medicamentos
|
|
CA2476583C
(en)
|
2002-03-13 |
2011-07-05 |
Kristof Van Emelen |
Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
|
|
WO2003076401A1
(en)
|
2002-03-13 |
2003-09-18 |
Janssen Pharmaceutica N.V. |
Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
|
|
CN100396679C
(zh)
|
2002-03-13 |
2008-06-25 |
詹森药业有限公司 |
用作组蛋白脱乙酰化酶抑制剂的哌嗪基、哌啶基和吗啉基衍生物
|
|
JP4648628B2
(ja)
|
2002-03-13 |
2011-03-09 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼの新規な阻害剤としてのカルボニルアミノ誘導体
|
|
US6770729B2
(en)
|
2002-09-30 |
2004-08-03 |
Medtronic Minimed, Inc. |
Polymer compositions containing bioactive agents and methods for their use
|
|
WO2004033632A2
(en)
|
2002-10-04 |
2004-04-22 |
Bristol-Myers Squibb Company |
Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
|
|
SE0302116D0
(sv)
|
2003-07-21 |
2003-07-21 |
Astrazeneca Ab |
Novel compounds
|
|
CN100393718C
(zh)
|
2003-08-12 |
2008-06-11 |
霍夫曼-拉罗奇有限公司 |
作为npy拮抗剂的噻唑衍生物
|
|
JP2005119987A
(ja)
|
2003-10-15 |
2005-05-12 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
EP2316458A1
(en)
|
2004-09-20 |
2011-05-04 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
|
RU2405770C2
(ru)
|
2005-09-27 |
2010-12-10 |
Сионоги Энд Ко., Лтд. |
Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
|
|
US20090143396A1
(en)
|
2005-10-12 |
2009-06-04 |
Malecha James W |
Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors
|
|
AR059355A1
(es)
|
2006-02-07 |
2008-03-26 |
Wyeth Corp |
Inhibidores de 11-beta hsd1
|
|
US8071779B2
(en)
|
2006-12-18 |
2011-12-06 |
Inspire Pharmaceuticals, Inc. |
Cytoskeletal active rho kinase inhibitor compounds, composition and use
|
|
WO2009158587A1
(en)
|
2008-06-26 |
2009-12-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
EP2400969A4
(en)
|
2008-12-04 |
2012-05-16 |
Inspire Pharmaceuticals Inc |
METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITORY COMPOUNDS
|
|
CN102264737A
(zh)
|
2008-12-23 |
2011-11-30 |
雅培制药有限公司 |
抗病毒化合物
|
|
JP2013047189A
(ja)
|
2009-12-25 |
2013-03-07 |
Kyorin Pharmaceutical Co Ltd |
新規パラバン酸誘導体及びそれらを有効成分とする医薬
|
|
EP2523664A4
(en)
|
2010-01-13 |
2013-06-26 |
Tempero Pharmaceuticals Inc |
COMPOUNDS AND METHODS
|
|
WO2012012282A1
(en)
|
2010-07-19 |
2012-01-26 |
Inspire Pharmaceuticals, Inc. |
Bifunctional rho kinase inhibitor compounds, composition and use
|
|
EP2597953A4
(en)
|
2010-07-27 |
2013-12-25 |
Inspire Pharmaceuticals Inc |
METHOD FOR THE TREATMENT OF EYE DISEASES USING KINASE-INHIBITOR COMPOUNDS IN PRODRUG FORMS
|
|
WO2013157021A1
(en)
|
2012-04-20 |
2013-10-24 |
Advinus Therapeutics Limited |
Bicyclic compounds, compositions and medicinal applications thereof
|
|
US20150376198A1
(en)
|
2013-02-18 |
2015-12-31 |
The Scripps Research Institute |
Modulators of vasopressin receptors with therapeutic potential
|
|
WO2015058163A2
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
|
JP6383418B2
(ja)
|
2013-11-27 |
2018-08-29 |
ジェネンテック， インコーポレイテッド |
置換ベンズアミド及びその使用方法
|
|
CN105960237B
(zh)
|
2013-12-02 |
2020-03-31 |
凯莫森特里克斯股份有限公司 |
Ccr6化合物
|
|
LT3105218T
(lt)
|
2014-02-13 |
2019-12-10 |
Incyte Corp |
Ciklopropilaminai kaip lsd1 inhibitoriai
|
|
US9974784B2
(en)
|
2015-01-21 |
2018-05-22 |
The Texas A&M University System |
Inhibitors of activin-like receptor kinases
|
|
WO2016161268A1
(en)
*
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
|
PE20180572A1
(es)
|
2015-06-18 |
2018-04-04 |
Cephalon Inc |
Derivados de piperidina 1,4-sustituidos
|
|
AU2016283105C1
(en)
|
2015-06-26 |
2023-02-02 |
Dana-Farber Cancer Institute, Inc. |
4,6-pyrimidinylene derivatives and uses thereof
|
|
WO2017070320A1
(en)
|
2015-10-21 |
2017-04-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Phenyl indole allosteric inhibitors of p97 atpase
|
|
US10766858B2
(en)
|
2016-03-30 |
2020-09-08 |
Genentech, Inc. |
Substituted benzamides and methods of use thereof
|
|
RU2018145734A
(ru)
|
2016-06-08 |
2020-07-14 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Химические соединения в качестве ингибиторов atf4 пути
|
|
JP7258748B2
(ja)
|
2016-11-22 |
2023-04-17 |
ダナ－ファーバー キャンサー インスティテュート， インコーポレイテッド |
サイクリン依存性キナーゼ１２（ｃｄｋ１２）の阻害剤およびその使用
|
|
WO2018106818A1
(en)
|
2016-12-07 |
2018-06-14 |
Kura Oncology, Inc. |
Methods of promoting beta cell proliferation
|
|
WO2019204505A2
(en)
|
2018-04-18 |
2019-10-24 |
Theras, Inc. |
K-ras modulators with a vinyl sulfonamide moiety
|
|
WO2019204442A1
(en)
|
2018-04-18 |
2019-10-24 |
Theras, Inc. |
K-ras modulators with a cyanoacrylamide moiety
|
|
SG11202013175SA
(en)
|
2018-06-29 |
2021-01-28 |
Kinnate Biopharma Inc |
Inhibitors of cyclin-dependent kinases
|
|
EP3820500A4
(en)
|
2018-07-13 |
2022-04-13 |
Teqla Therapeutics, Inc. |
USE OF BCL6 INHIBITORS TO TREAT AUTOIMMUNE DISEASES
|
|
EP4061341A4
(en)
|
2019-11-22 |
2024-04-10 |
The Regents of the University of California |
CASPASE6 INHIBITORS AND USES THEREOF
|
|
CN113135896B
(zh)
|
2020-01-18 |
2024-12-06 |
正大天晴药业集团股份有限公司 |
作为ret抑制剂的甲基吡唑类衍生物
|
|
WO2022173849A1
(en)
*
|
2021-02-10 |
2022-08-18 |
Qilu Regor Therapeutics Inc. |
(hetero)arylamino-cyclohexyl-sulfonyl derivatives as ccr6 inhibitors
|
|
MX2024002173A
(es)
*
|
2021-08-18 |
2024-03-26 |
Chemocentryx Inc |
Compuestos de arilsulfonilo como inhibidores de ccr6.
|